166 related articles for article (PubMed ID: 3539336)
1. A monoclonal antibody with binding and inhibiting activity towards human pancreatic carcinoma cells. I. Immunohistological and immunochemical characterization of a murine monoclonal antibody selecting for well differentiated adenocarcinomas of the pancreas.
Bosslet K; Kern HF; Kanzy EJ; Steinstraesser A; Schwarz A; Lüben G; Schorlemmer HU; Sedlacek HH
Cancer Immunol Immunother; 1986; 23(3):185-91. PubMed ID: 3539336
[TBL] [Abstract][Full Text] [Related]
2. Similarities in function between pancreatic tumor cells and macrophages and their inhibition by murine monoclonal antibodies.
Schorlemmer HU; Bosslet K; Kern HF; Sedlacek HH
Behring Inst Mitt; 1988 Apr; (82):240-64. PubMed ID: 3408453
[TBL] [Abstract][Full Text] [Related]
3. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
Woodhouse CS; Morgan AC
Cancer Res; 1989 May; 49(10):2766-72. PubMed ID: 2713860
[TBL] [Abstract][Full Text] [Related]
4. Tissue distribution, immunochemical characterization, and biosynthesis of 47D10, a tumor-associated surface glycoprotein.
Ho MK; Kato KP; Durda PJ; Murray JH; Wolfe H; Rabin H; Carney WP
Cancer Res; 1987 Jan; 47(1):241-50. PubMed ID: 3539319
[TBL] [Abstract][Full Text] [Related]
5. Human pancreatic cancer-associated antigens detected by murine monoclonal antibodies.
Yuan SZ; Ho JJ; Yuan M; Kim YS
Cancer Res; 1985 Dec; 45(12 Pt 1):6179-87. PubMed ID: 4063969
[TBL] [Abstract][Full Text] [Related]
6. Retargeting of human lymphocytes against human ovarian carcinoma cells by bispecific antibodies: from laboratory to clinic.
Mezzanzanica D; Canevari S; Colnaghi MI
Int J Clin Lab Res; 1991; 21(2):159-64. PubMed ID: 1815760
[TBL] [Abstract][Full Text] [Related]
7. Radiolocalization of human small cell lung cancer and antigen-positive normal tissues using monoclonal antibody LS2D617.
Wilson BS; Petrella E; Lowe SR; Lien K; Mackensen DG; Gridley DS; Stickney DR
Cancer Res; 1990 May; 50(10):3124-30. PubMed ID: 2159374
[TBL] [Abstract][Full Text] [Related]
8. Single-chain antibodies in pancreatic cancer.
Colcher D; Pavlinkova G; Beresford G; Booth BJ; Batra SK
Ann N Y Acad Sci; 1999 Jun; 880():263-80. PubMed ID: 10415872
[TBL] [Abstract][Full Text] [Related]
9. Modification of monoclonal antibody carbohydrates by oxidation, conjugation, or deoxymannojirimycin does not interfere with antibody effector functions.
Awwad M; Strome PG; Gilman SC; Axelrod HR
Cancer Immunol Immunother; 1994 Jan; 38(1):23-30. PubMed ID: 8299115
[TBL] [Abstract][Full Text] [Related]
10. Production and characterization of monoclonal antibody to a 60-kD glycoprotein in ovarian carcinoma.
Bhattacharya M; Chatterjee SK; Gangopadhyay A; Barlow JJ
Hybridoma; 1985; 4(2):153-62. PubMed ID: 3891588
[TBL] [Abstract][Full Text] [Related]
11. A tumor-associated antigen in carcinoma of the pancreas defined by monoclonal antibody B72.3.
Lyubsky S; Madariaga J; Lozowski M; Mishriki Y; Schuss A; Chao S; Lundy J
Am J Clin Pathol; 1988 Feb; 89(2):160-7. PubMed ID: 3277379
[TBL] [Abstract][Full Text] [Related]
12. Generation and application of monoclonal antibody to human pancreatic carcinoma.
Yuan S; Zhang H; Chen Q
Hybridoma; 1996 Aug; 15(4):289-93. PubMed ID: 8880216
[TBL] [Abstract][Full Text] [Related]
13. The role of monocytes and natural killer cells in mediating antibody-dependent lysis of colorectal tumour cells.
Abdullah N; Greenman J; Pimenidou A; Topping KP; Monson JR
Cancer Immunol Immunother; 1999 Dec; 48(9):517-24. PubMed ID: 10602889
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
[TBL] [Abstract][Full Text] [Related]
15. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
Johnston WW
Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
[TBL] [Abstract][Full Text] [Related]
16. Chimeric B72.3 mouse/human (IgG1) antibody directs the lysis of tumor cells by lymphokine-activated killer cells.
Primus FJ; Pendurthi TK; Hutzell P; Kashmiri S; Slavin DC; Callahan R; Schlom J
Cancer Immunol Immunother; 1990; 31(6):349-57. PubMed ID: 2386980
[TBL] [Abstract][Full Text] [Related]
17. An assessment of prolonged reactivity of seven monoclonal antibodies against CX-1 tumor xenografts using a hand-held gamma-detecting probe.
Nieroda CA; Siddiqi MA; Hinkle GH; Hill TL; Mojzisik C; Olsen J; Rousseau M; Gersman M; Houchens DP; Sardi A
J Invest Surg; 1989; 2(3):227-40. PubMed ID: 2487252
[TBL] [Abstract][Full Text] [Related]
18. TAG-72-reactive antibody CC49 recognizes molecules expressed by hematopoietic cell lines.
Nicolet CM; Siegel DH; Surfus JE; Sondel PM
Tumour Biol; 1997; 18(6):356-66. PubMed ID: 9372869
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen.
Shaw DR; Khazaeli MB; Sun LK; Ghrayeb J; Daddona PE; McKinney S; LoBuglio AF
J Immunol; 1987 Jun; 138(12):4534-8. PubMed ID: 3584980
[TBL] [Abstract][Full Text] [Related]
20. Immunological tailoring of monoclonal antibodies for immunotherapy of pancreatic carcinoma.
Bosslet K; Döring N; Seemann G; Schulz G; Sedlacek HH
Int J Cancer Suppl; 1988; 2():85-8. PubMed ID: 3162450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
